AlphAlerts

US Stocks - Insider Trading disclosures made made on Mar 31, 2025

View 400 US Stocks - Insider Trading disclosures made on US Exchanges on Mar 31, 2025.

The latest disclosure under SEC insider trading regulations was reported by Stagwell Inc - Ordinary Shares - Class A., where the revocation of 151,648,741 Class A Common Stock of common stock was executed . This transaction was reported to the Securities and Exchange Commission on March 31, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Stagwell Inc - Ordinary Sh...
Mark Penn J. Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 151,648,741 151,778,741 - - Class A Common Stock
Stagwell Inc - Ordinary Sh...
Mark Penn J. Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 151,648,741 0 - - Class C Common Stock
UWM Holdings Corporation -...
Mathew Ishbia Director, President and CEO, Ten Percent Owner 31 Mar 2025 13,028,909 13,028,909 - - Class A Common Stock
UWM Holdings Corporation -...
Mathew Ishbia Director, President and CEO, Ten Percent Owner 31 Mar 2025 13,028,909 1,397,782,620 - - UWM Paired Interests
UWM Holdings Corporation -...
Mathew Ishbia Director, President and CEO, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 31 Mar 2025 13,028,909 0 - - Class A Common Stock
SS Innovations Internation...
Sudhir Srivastava Director, Chairman and CEO, Ten Percent Owner 31 Mar 2025 5,811,554 112,926,514 - 1.4 8,019,945 Common Stock, $0.0001 par value
Mawson Infrastructure Grou...
Rahul Mewawalla Director, Director, CEO, President, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 1,587,302 3,496,194 - - Common Stock
Mawson Infrastructure Grou...
Rahul Mewawalla Director, Director, CEO, President, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 1,587,302 0 - - Restricted Stock Units
Intuitive Machines Inc - O...
Kamal Seyed Ghaffarian Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 31 Mar 2025 1,292,729 36,496,032 - - Common Units
Intuitive Machines Inc - O...
Kamal Seyed Ghaffarian Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 31 Mar 2025 1,292,729 36,496,032 - - Class C Common Stock
Crowdstrike Holdings Inc -...
George R. Kurtz Director, PRESIDENT AND CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Mar 2025 1,246,087 0 (0%) 3% 0 Class A common stock
Oncology Institute Inc (The)
Daniel Virnich Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 1,083,334 1,807,697 - 0 Common stock
Organon & Co.
Kevin Ali Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 1,072,607 1,072,607 - - Stock Option (right to buy)
Crowdstrike Holdings Inc -...
George R. Kurtz Director, PRESIDENT AND CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Mar 2025 1,021,038 0 (0%) 2% 0 Class A common stock
Crowdstrike Holdings Inc -...
George R. Kurtz Director, PRESIDENT AND CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Mar 2025 940,788 0 (0%) 2% 0 Class A common stock
Pyxis Oncology Inc
Lara S. Sullivan Director, President ,CEO & CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 918,308 918,308 - - Stock Option (Right to Buy)
Arbutus Biopharma Corp
Tuan Nguyen Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 750,000 750,000 - - Stock Option (Right to Buy)
Arbutus Biopharma Corp
Tuan Nguyen Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 750,000 750,000 - - Stock Option (Right to Buy)
First Horizon Corporation
D. Bryan Jordan Director, Chairman, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Mar 2025 725,848 1,197,797 (0%) 0% 0 Common Stock
Mawson Infrastructure Grou...
Rahul Mewawalla Director, Director, CEO, President, Ten Percent Owner Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. 31 Mar 2025 633,713 2,862,481 - 0.5 316,857 Common Stock
ADT Inc
Donald M. Young EVP & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 614,637 2,947,342 (0%) 0% 0 Common Stock
Ryerson Holding Corp.
Edward J. Lehner Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 600,000 600,000 - - Restricted Stock Units
Exelixis Inc
Michael M. Morrissey Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 589,719 1,623,009 (0%) 0% 0 Common Stock
ADT Inc
Jeff Likosar Pres Corp Dev & Trans. & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 573,387 1,698,218 (0%) 0% 0 Common Stock
ADT Inc
Jeff Likosar Pres Corp Dev & Trans. & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 573,387 1,263,781 (0%) 0% 0 Common Stock
ADT Inc
James D. DeVries Director, Chairman, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 559,597 3,565,937 (0%) 0% 0 Common Stock
OPAL Fuels Inc - Ordinary ...
Jonathan Maurer Co-Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 489,429 489,429 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Adam Comora Co-Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 489,429 489,429 - - Restricted Stock Units
Local Bounti Corp - Ordina...
Charles R. Schwab Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Mar 2025 429,137 429,137 - - Series A Convertible Preferred Stock
Pyxis Oncology Inc
Pamela Yanchik Connealy CFO & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 414,163 414,163 - - Stock Option (Right to Buy)
Stardust Power Inc.
Chris Celano Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 408,719 408,719 - 0 Common Stock
ADT Inc
Jeff Likosar Pres Corp Dev & Trans. & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 397,410 1,720,945 - - Employee Stock Option (right to buy)
ADT Inc
Jeff Likosar Pres Corp Dev & Trans. & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 397,410 1,720,945 - - Employee Stock Option (right to buy)
ADT Inc
James D. DeVries Director, Chairman, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 387,853 1,840,278 - - Employee Stock Option (right to buy)
C3.ai Inc - Ordinary Share...
James Hageman Snabe Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 360,000 370,000 - 0 Class A Common Stock
ADT Inc
Donald M. Young EVP & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 356,160 1,503,420 - - Employee Stock Option (right to buy)
Starwood Property Trust Inc
Barry S. Sternlicht Director, CEO, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 345,833 2,245,835 - - Restricted Stock Units
Starwood Property Trust Inc
Barry S. Sternlicht Director, CEO, Chairman of the Board Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 345,833 2,880,440 (1%) 0% - Common Stock
Organon & Co.
Matthew M. Walsh Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 317,656 317,656 - - Stock Option (right to buy)
Healthcare Triangle Inc
Lakshmanan Kannappan Business Head Other type of transaction at price $ 0.00 per share. 31 Mar 2025 304,180 324,180 - 0 Common Stock
StoneX Group Inc
Sean M. O'Connor Director, Executive Vice-Chairman-Board Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 300,000 1,057,167 (5%) 1% 0 Restricted Shares of Common Stock
Hyperfine Inc - Ordinary S...
Thomas Teisseyre Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 300,000 382,213 - 0 Class A Common Stock
Hyperfine Inc - Ordinary S...
Brett Hale CFO and CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 300,000 300,000 - 0 Class A Common Stock
CERo Therapeutics Holdings...
Brian G. Atwood Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 294,460 11,660 - - Pre-Funded Warrant
CERo Therapeutics Holdings...
Brian G. Atwood Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 294,460 490,534 - 0.0 29 Common Stock
OPAL Fuels Inc - Ordinary ...
Kazi Hasan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 293,657 293,657 - - Restricted Stock Units
Charles Schwab Corp.
Todd M. Ricketts Director Gift of securities by or to the insider at price $ 0.00 per share. 31 Mar 2025 290,608 525,805 (0%) 0% 0 Common Stock
Cidara Therapeutics Inc
Jeffrey Stein Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 275,000 275,000 - - Employee Stock Option (right to buy)
Ouster Inc - Ordinary Shar...
Angus Pacala Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 275,000 1,044,957 - 0 Common Stock
Atlas Lithium Corporation
Marc Fogassa Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 265,153 4,983,231 - 0 Common Stock
Pyxis Oncology Inc
Jitendra Wadhane SVP, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 263,782 263,782 - - Stock Option (Right to Buy)
Organon & Co.
Joseph T. Morrissey Head of Manufacturing Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 247,524 247,524 - - Stock Option (right to buy)
AudioEye Inc
David Moradi Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 241,444 1,105,867 (12%) 2% 0 Common Stock
Abercrombie & Fitch Co. - ...
Fran Horowitz-Bonadies Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 230,096 811,703 (1%) 0% 0 Class A Common Stock
Clear Channel Outdoor Hold...
Justin Cochrane Former CEO, UK & Europe Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 221,759 1,191,623 (2%) 0% 0 Common Stock
OPAL Fuels Inc - Ordinary ...
Kazi Hasan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 220,243 220,243 - - Restricted Stock Units
Organon & Co.
Kevin Ali Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 218,267 218,267 - - Restricted Stock Units
Dyne Therapeutics Inc
Erick J. Lucera Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 214,500 214,500 - - Stock Option (Right to Buy)
Organon & Co.
Juan Camilo Arjona Ferreira Head of R&D & CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 198,019 198,019 - - Stock Option (right to buy)
Oncology Institute Inc (The)
Robert Ross Carter Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 197,368 236,775 - 0 Class A Common Stock
OPAL Fuels Inc - Ordinary ...
John Coghlin General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 195,772 195,772 - - Restricted Stock Units
Hallador Energy Co
Brent K. Bilsland Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.28 per share. 31 Mar 2025 194,258 1,143,235 (3%) 0% 12.3 2,385,488 COMMON STOCK
Stagwell Inc - Ordinary Sh...
Mark Penn J. Director, Chief Executive Officer, Ten Percent Owner Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share. 31 Mar 2025 191,354 2,367,654 - 5.9 1,134,729 Class A Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 181,518 181,518 - - Stock Option (right to buy)
Organon & Co.
Kirke Weaver Gen. Counsel & Corp. Secy. Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 181,518 181,518 - - Stock Option (right to buy)
Commercial Vehicle Group Inc
Chung Kin Cheung EVP & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 181,132 316,352 (1%) 0% 0 Common Stock, $0.01 par value
Macy`s Inc
Adrian V. Mitchell EVP, COO & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 171,526 0 - - Restricted Stock Units
Macy`s Inc
Adrian V. Mitchell EVP, COO & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 171,526 337,834 (0%) 0% 0 Common Stock
OPAL Fuels Inc - Ordinary ...
David Unger Executive Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 171,300 171,300 - - Restricted Stock Units
Exelixis Inc
Christopher J. Senner EVP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 170,009 1,009,264 (0%) 0% 0 Common Stock
SS Innovations Internation...
Sudhir Srivastava Director, Chairman and CEO, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 31 Mar 2025 165,000 112,761,514 - 0 Common Stock, $0.0001 par value
TJX Companies, Inc.
Ernie L. Herrman Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 164,450 630,639 (0%) 0% 0 Common Stock
Oncology Institute Inc (The)
Jeremy N Castle Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 162,281 252,667 - 0 Common stock
Corcept Therapeutics Inc
Joseph Douglas Lyon See Remarks Sale of securities on an exchange or to another person at price $ 100.22 per share. 31 Mar 2025 162,008 47,001 (0%) 0% 100.2 16,236,571 Common Stock
Exelixis Inc
Amy C. Peterson EVP Prod Dev & Med Aff & CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 159,383 506,472 (0%) 0% 0 Common Stock
Exelixis Inc
Patrick J. Haley EVP, Commercial Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 159,383 500,411 (0%) 0% 0 Common Stock
Oncology Institute Inc (The)
Yale Podnos Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 157,088 236,137 - 0 Common stock
Alto Ingredients Inc
Bryon T. McGregor Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 155,500 989,765 (1%) 0% 0 Common Stock
Exelixis Inc
Jeffrey J. Hessekiel EVP & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 154,070 751,678 (0%) 0% 0 Common Stock
Savara Inc
David A. Ramsay Director Purchase of securities on an exchange or from another person at price $ 2.78 per share. 31 Mar 2025 150,000 2,513,642 (4%) 0% 2.8 416,250 Common Stock
FitLife Brands Inc
Dayton Judd Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.62 per share. 31 Mar 2025 144,000 1,031,226 - 2.6 377,280 Common Stock
FitLife Brands Inc
Dayton Judd Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 144,000 0 - - Stock Options
Ardent Health Partners Inc
Martin J. Bonick Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 134,927 1,126,984 - 0 Common Stock
Exelixis Inc
Dana T. Aftab CSO/EVP Disc & Trans Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 132,819 693,936 (0%) 0% 0 Common Stock
FrontView REIT Inc.
Randall Starr Director, Co-CEO and Co-President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 130,500 130,500 - - Restricted Stock Units
Timken Co.
Richard Kyle Director, Interim President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 126,700 286,963 (0%) 0% 0 Common Stock
Organon & Co.
Vittorio Nisita Head of Global Business Svcs Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 123,762 123,762 - - Stock Option (right to buy)
AT&T, Inc.
Pascal Desroches Sr. Exec VP and CFO Grant, award, or other acquisition of securities at price $ 28.28 per share. 31 Mar 2025 118,119 121,297 (0%) 0% 28.3 3,340,417 Common Stock
Cipher Mining Inc
Tyler Page Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 113,225 5,530,662 - - Common Stock
Cipher Mining Inc
Tyler Page Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 113,225 5,213,601 - - Restricted Stock Units
Kohl`s Corp.
Nicholas David George Jones Chief Merchandising Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 112,469 171,904 (0%) 0% - Common Stock
Kohl`s Corp.
Jill Timm Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 112,469 360,309 (0%) 0% - Common Stock
OPAL Fuels Inc - Ordinary ...
Darrell Birck Executive Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 110,122 110,122 - - Restricted Stock Units
Stagwell Inc - Ordinary Sh...
Mark Penn J. Director, Chief Executive Officer, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Mar 2025 106,746 2,559,008 - 0 Class A Common Stock
Clear Channel Outdoor Hold...
Justin Cochrane Former CEO, UK & Europe Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.11 per share. 31 Mar 2025 105,703 969,864 (1%) 0% 1.1 117,330 Common Stock
Hallador Energy Co
Brent K. Bilsland Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 105,079 210,157 - - RSU
Clear Channel Outdoor Hold...
Justin Cochrane Former CEO, UK & Europe Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.11 per share. 31 Mar 2025 104,782 1,086,841 (2%) 0% 1.1 116,308 Common Stock
Abercrombie & Fitch Co. - ...
Fran Horowitz-Bonadies Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.37 per share. 31 Mar 2025 103,200 708,503 (1%) 0% 76.4 7,881,384 Class A Common Stock
Macy`s Inc
Adrian V. Mitchell EVP, COO & CFO Sale of securities on an exchange or to another person at price $ 12.88 per share. 31 Mar 2025 101,633 236,201 (0%) 0% 12.9 1,309,033 Common Stock
Silence Therapeutics Plc -...
Richard Ian Griffiths Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Mar 2025 100,000 9,861,299 - - American Depositary Shares
Corcept Therapeutics Inc
Sean Maduck See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.27 per share. 31 Mar 2025 100,000 185,622 (0%) 0% 8.3 827,000 Common Stock
Corcept Therapeutics Inc
Sean Maduck See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 100,000 300,000 - - Stock option (right to buy)
Organon & Co.
Daniel Karp Executive VP, Corp. Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 99,009 99,009 - - Stock Option (right to buy)
Hallador Energy Co
Heath Aaron Lovell President-Hallador Power Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.28 per share. 31 Mar 2025 98,835 166,867 (0%) 0% 12.3 1,213,694 COMMON STOCK
First Guaranty Bancshares Inc
William K. Hood Director Purchase of securities on an exchange or from another person at price $ 8.47 per share. 31 Mar 2025 98,460 98,460 (1%) 1% 8.5 833,956 COMMON STOCK
Palantir Technologies Inc ...
Ryan Taylor See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 98,177 32,307 - - Class B Common Stock
Palantir Technologies Inc ...
Ryan Taylor See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 98,177 501,348 - - Class A Common Stock
Kohl`s Corp.
Fred Hand SEVP, Director of Stores Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 97,800 257,453 (0%) 0% - Common Stock
Commercial Vehicle Group Inc
Aneezal H. Mohamed Chief Legal Ofc, Cmp Ofc & Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 96,855 271,475 (0%) 0% 0 Common Stock, $0.01 par value
Procore Technologies Inc
Craig F. Courtemanche Director, CEO & President, Chairman of the Board Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 93,437 815,616 - 0 Common Stock
Hallador Energy Co
Brent K. Bilsland Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 89,179 0 - - Restricted Stock Unit
Commercial Vehicle Group Inc
Kristin S Mathers Chief HR Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 86,038 161,269 (0%) 0% 0 Common Stock, $0.01 par value
OPAL Fuels Inc - Ordinary ...
Scott Edelbach Executive Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 85,650 85,650 - - Restricted Stock Units
Frontdoor Inc.
William C. Cobb Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 84,144 84,144 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
David Unger Executive Vice President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 80,704 138,026 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
David Unger Executive Vice President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 80,704 80,703 - - Restricted Stock Units
Purple Innovation Inc - Or...
Robert T. DeMartini Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 80,386 902,746 (4%) 0% - Class A Common Stock
Purple Innovation Inc - Or...
Robert T. DeMartini Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 80,386 160,771 - - Restricted Stock Units
TJX Companies, Inc.
Ernie L. Herrman Director, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.80 per share. 31 Mar 2025 79,512 551,127 (0%) 0% 121.8 9,684,562 Common Stock
Corcept Therapeutics Inc
Sean Maduck See Remarks Sale of securities on an exchange or to another person at price $ 100.26 per share. 31 Mar 2025 79,277 106,345 (0%) 0% 100.3 7,947,995 Common Stock
Climb Bio Inc.
Douglas E. Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 78,873 78,873 - - Stock Option (Right to Buy)
Techprecision Corp
Phillip E. Podgorski Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 78,261 78,261 - 0 Common Stock
National Vision Holdings Inc
Christopher Laden Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 78,248 78,248 - - Restricted Stock Units
National Cinemedia Inc
Thomas F. Lesinski Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 77,500 0 - - Restricted Stock Units
National Cinemedia Inc
Thomas F. Lesinski Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 77,500 407,041 (0%) 0% 0 Common Stock
Beam Therapeutics Inc
John Evans Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 77,500 1,016,159 (2%) 0% 0 Common Stock
TJX Companies, Inc.
Carol Meyrowitz Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 75,437 245,084 (0%) 0% 0 Common Stock
Corcept Therapeutics Inc
Joseph Douglas Lyon See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 75,000 0 - - Stock option (right to buy)
Corcept Therapeutics Inc
Joseph Douglas Lyon See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.52 per share. 31 Mar 2025 75,000 119,009 (0%) 0% 16.5 1,239,000 Common Stock
LifeMD Inc
Nicholas Alvarez Chief Acquisition Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 75,000 580,000 - 0 Common Shares
LifeMD Inc
Marc David Benathen Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 75,000 464,554 - 0 Common Stock
Ryerson Holding Corp.
Edward J. Lehner Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 73,700 705,369 (1%) 0% 0 Common Stock (par value $0.01 per share)
Core & Main Inc - Ordinary...
Mark R. Witkowski Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 73,458 73,458 - - Options (Rights to Buy)
Kohl`s Corp.
Jennifer J. Kent Sr.EVP & CLO & Corp. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 73,350 203,825 (0%) 0% - Common Stock
Kohl`s Corp.
Christie Raymond Sr. EVP & Chief Marketing Off. Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 73,350 256,701 (0%) 0% - Common Stock
Local Bounti Corp - Ordina...
Charles R. Schwab Director Purchase of securities on an exchange or from another person at price $ 2.00 per share. 31 Mar 2025 70,863 70,863 - 2 141,726 Common Stock
Procore Technologies Inc
Steven Scott Davis PRESIDENT PRODUCT & TECHNOLOGY Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 68,281 225,074 - 0 Common Stock
OPAL Fuels Inc - Ordinary ...
Jonathan Maurer Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 67,205 175,943 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
Jonathan Maurer Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 67,205 134,408 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Adam Comora Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 67,205 160,918 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
Adam Comora Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 67,205 134,408 - - Restricted Stock Units
British American Tobacco P...
Tadeu Marroco Executive Director,Chief Executive Officer 31 Mar 2025 67,109 214,067 (0%) 0% 0 Ords 0.25p
Stagwell Inc - Ordinary Sh...
Frank P. Lanuto Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share. 31 Mar 2025 66,948 594,328 - 5.9 397,002 Class A Common Stock
Dyne Therapeutics Inc
Erick J. Lucera Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 66,100 66,100 - 0 Common Stock
OPAL Fuels Inc - Ordinary ...
Betsy L. Battle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 66,073 66,073 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
James J. Martell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 66,073 66,073 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Ashok Vemuri Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 66,073 66,073 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Kevin M. Fogarty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 66,073 66,073 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Scott Dols Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 66,073 66,073 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Mark S. Comora Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 66,073 66,073 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Nadeem Nisar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 66,073 66,073 - - Restricted Stock Units
Procore Technologies Inc
Howard Fu CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 64,687 209,400 - 0 Common Stock
Organon & Co.
Matthew M. Walsh Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 64,640 64,640 - - Restricted Stock Units
Lulus Fashion Lounge Holdi...
Crystal Landsem Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. 31 Mar 2025 63,456 1,992,423 - 0.4 25,382 Common Stock
Omega Healthcare Investors...
C. Taylor Pickett Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 62,623 572,046 - - Profits Interest Units
Omega Healthcare Investors...
C. Taylor Pickett Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 62,623 888,588 - - OP Units
Carvana Co. - Ordinary Sha...
Benjamin Huston Chief Operating Officer 31 Mar 2025 62,500 91,449 - - Class B Units
RAPT Therapeutics Inc
Mary Ann Gray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 61,202 61,202 - - Director Stock Option (right to buy)
Omega Healthcare Investors...
C. Taylor Pickett Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 60,460 825,965 - - OP Units
Omega Healthcare Investors...
C. Taylor Pickett Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 60,460 634,669 - - Profits Interest Units
Starwood Property Trust Inc
Barry S. Sternlicht Director, CEO, Chairman of the Board Other type of transaction at price $ 0.00 per share. 31 Mar 2025 59,676 2,820,764 (0%) 0% 0 Common Stock
Stagwell Inc - Ordinary Sh...
Jay Leveton President Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share. 31 Mar 2025 59,400 474,961 - 5.9 352,242 Class A Common Stock
Alto Ingredients Inc
Bryon T. McGregor Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. 31 Mar 2025 58,929 930,836 (1%) 0% 1.1 66,000 Common Stock
Hallador Energy Co
Heath Aaron Lovell President-Hallador Power Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 57,971 0 - - Restricted Stock Unit
Cipher Mining Inc
Tyler Page Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.30 per share. 31 Mar 2025 57,802 5,472,860 - 2.3 132,945 Common Stock
Lulus Fashion Lounge Holdi...
Mark Vos President & CIO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. 31 Mar 2025 57,563 1,294,776 - 0.4 23,025 Common Stock
Procore Technologies Inc
Lawrence Joseph Stack Chief Revenue Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 57,500 218,868 - 0 Common Stock
ContextLogic Inc - Ordinar...
Jennifer Kwon Chou Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 56,701 56,701 - - Restricted Stock Unit
Hallador Energy Co
Brent K. Bilsland Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. 31 Mar 2025 55,849 1,087,388 (3%) 0% 12.3 685,826 Common Stock
Alto Ingredients Inc
Robert R. Olander Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 55,500 280,556 (0%) 0% 0 Common Stock
Alto Ingredients Inc
Todd E. Benton COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 55,500 189,112 (0%) 0% 0 Common Stock
AMMO Inc
Fred W. Wagenhals Director, EXECUTIVE CHAIR 31 Mar 2025 55,000 7,334,449 - 0 Common Stock
Ardent Health Partners Inc
Alfred Lumsdaine Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 53,971 214,536 - 0 Common Stock
Hallador Energy Co
Brent K. Bilsland Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. 31 Mar 2025 53,032 1,090,203 (3%) 0% 12.3 651,233 COMMON STOCK
Abercrombie & Fitch Co. - ...
Scott D. Lipesky EVP and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 52,296 163,734 (0%) 0% 0 Class A Common Stock
Ryerson Holding Corp.
Edward J. Lehner Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.96 per share. 31 Mar 2025 52,140 653,229 (1%) 0% 23.0 1,197,134 Common Stock (par value $0.01 per share)
Lululemon Athletica inc.
Calvin R. McDonald Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 51,315 51,315 - - Stock Option (right to buy)
Sarcos Technology and Robo...
Kristi Martindale Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 5.82 per share. 31 Mar 2025 51,141 325,079 - 5.8 297,436 Common Stock
Organon & Co.
Joseph T. Morrissey Head of Manufacturing Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 50,369 50,369 - - Restricted Stock Units
Anavex Life Sciences Corpo...
Athanasios Skarpelos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 50,000 50,000 - - Stock Option (Right to Buy)
Anavex Life Sciences Corpo...
Steffen Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 50,000 50,000 - - Stock Option (Right to Buy)
Anavex Life Sciences Corpo...
Peter Donhauser Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 50,000 50,000 - - Stock Option (Right to Buy)
Anavex Life Sciences Corpo...
Claus van der Velden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 50,000 50,000 - - Stock Option (Right to Buy)
Anavex Life Sciences Corpo...
Jiong Ma Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 50,000 50,000 - - Stock Option (Right to Buy)
Cidara Therapeutics Inc
Shane M. Ward COO & CLO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 50,000 50,000 - - Employee Stock Option (right to buy)
Corcept Therapeutics Inc
Joseph Douglas Lyon See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 50,000 50,000 - - Stock option (right to buy)
Corcept Therapeutics Inc
Joseph Douglas Lyon See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.26 per share. 31 Mar 2025 50,000 209,009 (0%) 0% 19.3 963,000 Common Stock
Carvana Co. - Ordinary Sha...
Benjamin Huston Chief Operating Officer 31 Mar 2025 50,000 173,803 (0%) 0% 0 Class A Common Stock
SharpLink Gaming Ltd
Leslie Bernhard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 50,000 50,000 - - Restricted Stock Units
SharpLink Gaming Ltd
Robert M. Gutkowski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 50,000 50,000 - - Restricted Stock Units
SharpLink Gaming Ltd
Obie McKenzie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 50,000 50,000 - - Restricted Stock Units
RAPT Therapeutics Inc
Wendye Robbins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 49,432 49,432 - - Director Stock Option (right to buy)
Unisys Corp.
Peter A. Altabef Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.59 per share. 31 Mar 2025 49,183 1,354,866 (2%) 0% 4.6 225,750 Common Stock
Organon & Co.
Kevin Ali Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 48,758 97,518 - - Restricted Stock Units
Organon & Co.
Kevin Ali Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 48,758 248,677 - 0 Common Stock
Custom Truck One Source Inc
Marshall A. Heinberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 48,346 48,346 - - Restricted Stock Unit
Alto Ingredients Inc
James R Sneed Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 47,834 429,221 (0%) 0% 0 Common Stock
Alto Ingredients Inc
Auste M. Graham CLO & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 47,834 277,958 (0%) 0% 0 Common Stock
Sonim Technologies Inc
James S. Cassano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 46,728 72,507 (0%) 0% 0 Common Stock
Sonim Technologies Inc
Michael C. Mulica Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 46,728 101,110 (0%) 0% 0 Common Stock
Sonim Technologies Inc
Jack Steenstra Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 46,728 72,520 (0%) 0% 0 Common Stock
Biodesix Inc
John Patience Director, Chairman Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 46,686 384,612 - - Common Stock
Biodesix Inc
John Patience Director, Chairman Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 46,686 0 - - Restricted Stock Units
Biodesix Inc
Charles Watts Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 46,686 421,705 - - Common Stock
Biodesix Inc
Charles Watts Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 46,686 0 - - Restricted Stock Units
TJX Companies, Inc.
Ernie L. Herrman Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 45,978 597,105 (0%) 0% 0 Common Stock
TJX Companies, Inc.
Douglas W. Mizzi SEVP - Group President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 45,263 274,725 (0%) 0% 0 Common Stock
Ulta Beauty Inc
Kecia Steelman L. President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 44,429 44,429 - - Stock Option (right to buy)
Unisys Corp.
Peter A. Altabef Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 44,248 1,371,708 (2%) 0% 0 Common Stock
TJX Companies, Inc.
Kenneth Canestrari SEVP - Group President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 43,754 140,212 (0%) 0% 0 Common Stock
AMMO Inc
Jared R. Smith Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 43,333 479,807 - 0 Common Stock
Solid Power Inc - Ordinary...
John C. Van Scoter Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.08 per share. 31 Mar 2025 42,841 1,267,609 - 1.1 46,268 Common Stock
Nauticus Robotics Inc
Victoria Hay Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 42,798 42,798 - - Restricted Stock Units
Hallador Energy Co
Heath Aaron Lovell President-Hallador Power Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 40,864 81,728 - - RSU
Abercrombie & Fitch Co. - ...
Samir Desai EVP;Chief Digital&Tech Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 40,342 74,805 (0%) 0% 0 Class A Common Stock
Organon & Co.
Juan Camilo Arjona Ferreira Head of R&D & CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 40,295 40,295 - - Restricted Stock Units
Organon & Co.
Kathryn DiMarco Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 40,295 40,295 - - Restricted Stock Units
Corcept Therapeutics Inc
Joseph Douglas Lyon See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 40,000 0 - - Stock option (right to buy)
Corcept Therapeutics Inc
Joseph Douglas Lyon See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.82 per share. 31 Mar 2025 40,000 159,009 (0%) 0% 15.8 632,800 Common Stock
LifeMD Inc
Maria Stan Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 40,000 167,500 - 0 Common Stock
LifeMD Inc
Maria Stan Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 40,000 127,500 - 0 Common Stock
Custom Truck One Source Inc
Marshall A. Heinberg Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 39,993 352,202 (0%) 0% 0 Common Stock
Custom Truck One Source Inc
Marshall A. Heinberg Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 39,993 0 - - Restricted Stock Unit
Procore Technologies Inc
Benjamin C. Singer Chief Legal Officer; Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 39,531 111,641 - 0 Common Stock
ON24 Inc
Sharat Sharan Director, President and Chief Executive, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 5.23 per share. 31 Mar 2025 39,196 3,164,092 - 5.2 205,187 Common Stock
Organon & Co.
Kevin Ali Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 38,974 260,687 - 0 Common Stock
Organon & Co.
Kevin Ali Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 38,974 38,974 - - Restricted Stock Units
National Cinemedia Inc
Ronnie Y. Ng Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 38,750 0 - - Restricted Stock Units
National Cinemedia Inc
Ronnie Y. Ng Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 38,750 161,289 (0%) 0% 0 Common Stock
FrontView REIT Inc.
Timothy D. Dieffenbacher Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 37,286 37,286 - - Restricted Stock Units
Hillenbrand Inc
Kimberly K. Ryan President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 37,102 37,102 - - Restricted Stock Units (Matching RSU Framework 03/31/2025)
Pyxis Oncology Inc
John L. Flavin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 36,979 36,979 - - Stock Option (Right to Buy)
Pyxis Oncology Inc
Freda C. Lewis-Hall Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 36,979 36,979 - - Stock Option (Right to Buy)
Pyxis Oncology Inc
Michael Metzger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 36,979 36,979 - - Stock Option (Right to Buy)
Pyxis Oncology Inc
Rachel Humphrey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 36,979 36,979 - - Stock Option (Right to Buy)
Pyxis Oncology Inc
Jakob Dupont Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 36,979 36,979 - - Stock Option (Right to Buy)
Pyxis Oncology Inc
Darren S. Cline Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 36,979 36,979 - - Stock Option (Right to Buy)
Pyxis Oncology Inc
Thomas Civik Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 36,979 36,979 - - Stock Option (Right to Buy)
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 36,937 36,937 - - Restricted Stock Units
Organon & Co.
Kirke Weaver Gen. Counsel & Corp. Secy. Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 36,937 36,937 - - Restricted Stock Units
Hallador Energy Co
Heath Aaron Lovell President-Hallador Power Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. 31 Mar 2025 36,915 129,952 (0%) 0% 12.3 453,316 COMMON STOCK
TJX Companies, Inc.
Carol Meyrowitz Director, Executive Chairman Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.80 per share. 31 Mar 2025 36,474 208,610 (0%) 0% 121.8 4,442,533 Common Stock
Ryerson Holding Corp.
Edward J. Lehner Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 36,300 36,300 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Jonathan Maurer Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 35,868 121,668 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
Jonathan Maurer Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 35,868 35,868 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Adam Comora Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 35,868 106,643 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
Adam Comora Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 35,868 35,868 - - Restricted Stock Units
Lyell Immunopharma Inc
Otis W. Brawley Director Purchase of securities on an exchange or from another person at price $ 0.56 per share. 31 Mar 2025 35,640 35,640 - 0.6 19,958 Common Stock
Hallador Energy Co
Heath Aaron Lovell President-Hallador Power Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. 31 Mar 2025 35,482 131,385 (0%) 0% 12.3 435,719 COMMON STOCK
National Cinemedia Inc
Thomas F. Lesinski Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.84 per share. 31 Mar 2025 35,480 371,561 (0%) 0% 5.8 207,203 Common Stock
Corcept Therapeutics Inc
Joseph K. Belanoff Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 94.72 per share. 31 Mar 2025 35,102 2,982,335 (2%) 0% 94.7 3,324,861 Common Stock
Beam Therapeutics Inc
Giuseppe Ciaramella President Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 35,000 197,650 (0%) 0% 0 Common Stock
Corcept Therapeutics Inc
Joseph Douglas Lyon See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 35,000 56,571 - - Stock option (right to buy)
Corcept Therapeutics Inc
Joseph Douglas Lyon See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.56 per share. 31 Mar 2025 35,000 44,009 (0%) 0% 13.6 474,600 Common Stock
Liquidity Services Inc
Mateus-Tique Jaime Director Sale of securities on an exchange or to another person at price $ 30.71 per share. 31 Mar 2025 35,000 259,562 (0%) 0% 30.7 1,074,850 Common Stock
Turtle Beach Corp
Cristopher Keirn Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 34,176 34,176 - - Restricted Stock Units
Healthcare Triangle Inc
Shibu Kizhakevilayil Director, Head of M&A 31 Mar 2025 34,129 54,129 - 0 Common Stock
Cipher Mining Inc
Patrick Kelly Co-President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 33,968 1,043,038 - - Common Stock
Cipher Mining Inc
Patrick Kelly Co-President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 33,968 2,014,081 - - Restricted Stock Units
Cipher Mining Inc
William Iwaschuk Co-President and CLO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 33,968 2,014,081 - - Restricted Stock Units
Cipher Mining Inc
William Iwaschuk Co-President and CLO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 33,968 967,378 - - Common Stock
Commercial Vehicle Group Inc
Angela M. O’Leary VP, Controller & Ch Acct Offcr Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 33,955 83,927 (0%) 0% 0 Common Stock, $0.01 par value
Palantir Technologies Inc ...
Ryan Taylor See Remarks Sale of securities on an exchange or to another person at price $ 83.44 per share. 31 Mar 2025 33,159 426,119 - 83.4 2,766,823 Class A Common Stock
Abbvie Inc
Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 210.54 per share. 31 Mar 2025 33,132 53,234 (0%) 0% 210.5 6,975,611 Common Stock, $0.01 par value
Corcept Therapeutics Inc
Joseph Douglas Lyon See Remarks Sale of securities on an exchange or to another person at price $ 101.37 per share. 31 Mar 2025 32,942 14,059 (0%) 0% 101.4 3,339,416 Common Stock
Timken Co.
Richard Kyle Director, Interim President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 32,400 32,400 - - Performance Based-Restricted Stock Units
GrafTech International Ltd.
Jean-Marc Germain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 31,609 102,761 - - Deferred Share Units
VYNE Therapeutics Inc
David Domzalski Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.58 per share. 31 Mar 2025 30,498 445,563 (1%) 0% 1.6 48,187 Common Stock
Hallador Energy Co
Marjorie A. Hargrave Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.28 per share. 31 Mar 2025 30,267 30,267 (0%) 0% 12.3 371,679 Common Stock
LifeMD Inc
Eric Yecies Chief Legal Officer & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 30,000 370,000 - 0 Common Stock
LifeMD Inc
Stefan Galluppi Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 30,000 165,449 - 0 Common Stock
GrafTech International Ltd.
Sachin M. Shivaram Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 29,741 29,741 - - Deferred Share Units
Abercrombie & Fitch Co. - ...
Scott D. Lipesky EVP and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.37 per share. 31 Mar 2025 29,210 134,524 (0%) 0% 76.4 2,230,768 Class A Common Stock
OPAL Fuels Inc - Ordinary ...
David Unger Executive Vice President Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share. 31 Mar 2025 29,093 108,933 - 1.8 53,531 Class A common stock
Aura Biosciences Inc
Teresa Marie Bitetti Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 29,000 29,000 - - Stock Option (Right to Buy)
Macy`s Inc
Antony Spring Director, Chairman & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 28,588 57,176 - - Restricted Stock Units
Macy`s Inc
Antony Spring Director, Chairman & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 28,588 349,832 (0%) 0% 0 Common Stock
Shoe Carnival, Inc.
Mark J. Worden Director, PRESIDENT & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.00 per share. 31 Mar 2025 28,412 283,261 (1%) 0% 22 625,064 Common Stock
Calumet Specialty Products...
Bruce Fleming EVP - MONTANA RENEWABLES Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 28,320 28,320 - - Restricted Stock Unit
Origin Materials Inc
John Hickox Director Grant, award, or other acquisition of securities at price $ 0.66 per share. 31 Mar 2025 28,254 588,288 - 0.7 18,749 Common Stock
Full House Resorts, Inc.
Daniel R. Lee Director, PRESIDENT & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 28,240 28,240 - - Employee Stock Option (right to buy)
Beam Therapeutics Inc
Amy Simon Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 27,500 96,305 (0%) 0% 0 Common Stock
Citizens, Inc. - Ordinary ...
Gerald W. Shields Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,472 0 - - Restricted Stock Units
Citizens, Inc. - Ordinary ...
Gerald W. Shields Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 27,472 27,472 - - Restricted Stock Units
Citizens, Inc. - Ordinary ...
Gerald W. Shields Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,472 303,942 (0%) 0% - Citizens, Inc. Class A Common Stock
Unisys Corp.
Peter A. Altabef Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.59 per share. 31 Mar 2025 27,406 1,327,460 (2%) 0% 4.6 125,794 Common Stock
OPAL Fuels Inc - Ordinary ...
Betsy L. Battle Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 56,712 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
Betsy L. Battle Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 0 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
James J. Martell Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 0 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
James J. Martell Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 41,151 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
Ashok Vemuri Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 56,712 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
Ashok Vemuri Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 0 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Kevin M. Fogarty Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 56,712 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
Kevin M. Fogarty Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 0 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Scott Dols Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 56,712 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
Scott Dols Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 0 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Mark S. Comora Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 56,712 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
Mark S. Comora Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 0 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Nadeem Nisar Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 0 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
Nadeem Nisar Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 27,218 86,712 - - Class A common stock
Jaguar Health Inc
James J. Bochnowski Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Mar 2025 27,002 27,002 - - Convertible Promissory Note
Jaguar Health Inc
James J. Bochnowski Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Mar 2025 27,002 27,002 - - Warrant to Purchase Common Stock
Ardent Health Partners Inc
David Schultz President Hospital Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 26,985 64,172 - 0 Common Stock
Stagwell Inc - Ordinary Sh...
Frank P. Lanuto Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Mar 2025 26,974 661,276 - 0 Class A Common Stock
Organon & Co.
Kevin Ali Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. 31 Mar 2025 26,964 221,713 - 14.5 391,248 Common Stock
Custom Truck One Source Inc
Georgia R. Nelson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 26,859 26,859 - - Restricted Stock Unit
Custom Truck One Source Inc
Mark D. Ein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 26,859 26,859 - - Restricted Stock Unit
Custom Truck One Source Inc
Paul T. Bader Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 26,859 26,859 - - Restricted Stock Unit
Custom Truck One Source Inc
Mary M. Jackson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 26,859 26,859 - - Restricted Stock Unit
Omega Healthcare Investors...
Robert O. Stephenson CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 26,659 492,432 - - OP Units
Omega Healthcare Investors...
Robert O. Stephenson CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 26,659 238,994 - - Profits Interest Units
Lululemon Athletica inc.
Calvin R. McDonald Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 26,530 116,452 (0%) 0% 0 Common Stock
Lululemon Athletica inc.
Calvin R. McDonald Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 26,530 0 - - Performance Share Units
Stagwell Inc - Ordinary Sh...
Jay Leveton President Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Mar 2025 26,075 534,361 - 0 Class A Common Stock
Occidental Petroleum Corp.
William R. Klesse Director 31 Mar 2025 25,900 208,889 (0%) 0% 21.3 551,670 Common Stock
Occidental Petroleum Corp.
William R. Klesse Director 31 Mar 2025 25,900 3,860 - - Warrants (Right to buy)
Lindblad Expeditions Holdi...
Natalya Leahy CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 25,890 315,446 (0%) 0% 0 Common Stock
GrafTech International Ltd.
Anthony R. Taccone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 25,862 168,911 - - Deferred Share Units
Omega Healthcare Investors...
Robert O. Stephenson CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 25,738 265,653 - - Profits Interest Units
Omega Healthcare Investors...
Robert O. Stephenson CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 25,738 465,773 - - OP Units
Abbvie Inc
Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 25,700 0 - - Option (Right to Buy)
Abbvie Inc
Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.02 per share. 31 Mar 2025 25,700 112,066 (0%) 0% 79.0 2,030,814 Common Stock, $0.01 par value
Abbvie Inc
Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 209.49 per share. 31 Mar 2025 25,700 86,366 (0%) 0% 209.5 5,383,893 Common Stock, $0.01 par value
Organon & Co.
Vittorio Nisita Head of Global Business Svcs Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 25,184 25,184 - - Restricted Stock Units
Abeona Therapeutics Inc
Vishwas Seshadri Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 4.78 per share. 31 Mar 2025 25,000 1,355,322 (1%) 0% 4.8 119,500 Common Stock
Kymera Therapeutics Inc
Bruce Jacobs Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 25,000 69,899 - - Stock Option (Right to Buy)
Kymera Therapeutics Inc
Bruce Jacobs Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. 31 Mar 2025 25,000 226,886 - 2.1 52,000 Common Stock
Cidara Therapeutics Inc
Shane M. Ward COO & CLO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 25,000 39,674 (0%) 0% 0 Common Stock
LifeMD Inc
Dennis Wijnker Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 25,000 150,000 - 0 Common Stock
Lindblad Expeditions Holdi...
Noah Brodsky Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 25,000 79,590 (0%) 0% 0 Common Stock
AMMO Inc
Paul Joseph Kasowski CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 25,000 76,013 - 0 Common Stock
First Guaranty Bancshares Inc
Bruce McAnally Director Purchase of securities on an exchange or from another person at price $ 8.47 per share. 31 Mar 2025 24,615 145,839 (1%) 0% 8.5 208,489 COMMON STOCK
Origin Materials Inc
Craig A. Rogerson Director Grant, award, or other acquisition of securities at price $ 0.66 per share. 31 Mar 2025 24,487 289,511 - 0.7 16,250 Common Stock
OPAL Fuels Inc - Ordinary ...
Jonathan Maurer Co-Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share. 31 Mar 2025 24,227 151,716 - 1.8 44,578 Class A common stock
OPAL Fuels Inc - Ordinary ...
Adam Comora Co-Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share. 31 Mar 2025 24,227 136,691 - 1.8 44,578 Class A common stock
Snap Inc - Ordinary Shares...
Michael J. O'Sullivan General Counsel Sale of securities on an exchange or to another person at price $ 8.60 per share. 31 Mar 2025 24,000 507,660 (0%) 0% 8.6 206,386 Class A Common Stock
Guardant Health Inc
Helmy Eltoukhy Director, Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 23,998 2,421,453 (2%) 0% 0 Common Stock
Guardant Health Inc
Helmy Eltoukhy Director, Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 23,998 167,980 - - Restricted Stock Units
Guardant Health Inc
AmirAli Talasaz Director, Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 23,998 167,980 - - Restricted Stock Units
Guardant Health Inc
AmirAli Talasaz Director, Co-Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 23,998 2,321,619 (2%) 0% 0 Common Stock
Safehold Inc
Jay Sugarman Director, CHAIRMAN AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 31 Mar 2025 23,926 1,804,622 (3%) 0% 0 Common Stock
Palantir Technologies Inc ...
Ryan Taylor See Remarks Sale of securities on an exchange or to another person at price $ 82.40 per share. 31 Mar 2025 23,913 459,278 - 82.4 1,970,496 Class A Common Stock
Frontdoor Inc.
Jessica P. Ross SVP & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 23,666 23,666 - - Restricted Stock Units
Macy`s Inc
Adrian V. Mitchell EVP, COO & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 23,585 166,308 (0%) 0% 0 Common Stock
Macy`s Inc
Adrian V. Mitchell EVP, COO & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 23,585 47,170 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
David Unger Executive Vice President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 23,522 132,455 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
David Unger Executive Vice President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 23,522 47,043 - - Restricted Stock Units
OPAL Fuels Inc - Ordinary ...
John Coghlin General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 23,521 80,959 - - Class A common stock
OPAL Fuels Inc - Ordinary ...
John Coghlin General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 23,521 208,335 - - Restricted Stock Units
Ryerson Holding Corp.
James J. Claussen Executive Vice President & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 23,450 94,454 (0%) 0% 0 Common Stock (par value $0.01 per share)
Dorian LPG Ltd
Oivind Lorentzen Director Sale of securities on an exchange or to another person at price $ 23.11 per share. 31 Mar 2025 23,386 48,933 (0%) 0% 23.1 540,450 Common Shares, $0.01 par value per share
Hallador Energy Co
Marjorie A. Hargrave Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 23,351 46,702 - - Restricted Stock Unit
Purple Innovation Inc - Or...
Robert T. DeMartini Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.76 per share. 31 Mar 2025 23,232 879,514 (4%) 0% 0.8 17,638 Class A Common Stock
Palantir Technologies Inc ...
Ryan Taylor See Remarks Sale of securities on an exchange or to another person at price $ 84.26 per share. 31 Mar 2025 22,948 403,171 - 84.3 1,933,507 Class A Common Stock
Alto Ingredients Inc
Auste M. Graham CLO & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. 31 Mar 2025 22,677 255,281 (0%) 0% 1.1 25,398 Common Stock
Wolfspeed Inc
Thomas H. Werner Director, Executive Chair, Chairman of the Board Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 22,500 241,335 (0%) 0% 0 COMMON STOCK
Ceco Environmental Corp.
Peter K. Johansson See Remarks Sale of securities on an exchange or to another person at price $ 22.80 per share. 31 Mar 2025 22,500 62,160 (0%) 0% 22.8 512,933 Common Stock
FrontView REIT Inc.
Drew Ireland Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 22,371 22,371 - - Restricted Stock Units
Ardent Health Partners Inc
Stephen C. Petrovich EVP, GC and Asst. Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 22,263 719,091 - 0 Common Stock
Custom Truck One Source Inc
Georgia R. Nelson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 22,218 105,804 (0%) 0% 0 Common Stock
Custom Truck One Source Inc
Georgia R. Nelson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 22,218 0 - - Restricted Stock Unit
Custom Truck One Source Inc
Mark D. Ein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 22,218 1,585,707 (3%) 0% 0 Common Stock
Custom Truck One Source Inc
Mark D. Ein Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 22,218 0 - - Restricted Stock Unit
Custom Truck One Source Inc
Paul T. Bader Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 22,218 93,804 (0%) 0% 0 Common Stock
Custom Truck One Source Inc
Paul T. Bader Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 22,218 0 - - Restricted Stock Unit
Custom Truck One Source Inc
Mary M. Jackson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 22,218 55,173 (0%) 0% 0 Common Stock
Custom Truck One Source Inc
Mary M. Jackson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 22,218 0 - - Restricted Stock Unit
Alto Ingredients Inc
Robert R. Olander Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. 31 Mar 2025 22,128 258,428 (0%) 0% 1.1 24,783 Common Stock
Clearwater Analytics Holdi...
Sandeep Sahai Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 21,991 886,672 - 0 Class A Common Stock
Clearwater Analytics Holdi...
Sandeep Sahai Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 21,991 329,861 - - Restricted Stock Unit
TJX Companies, Inc.
Douglas W. Mizzi SEVP - Group President Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.80 per share. 31 Mar 2025 21,885 252,840 (0%) 0% 121.8 2,665,593 Common Stock
Credo Technology Group Hol...
Chi Fung Cheng Director, Chief Technology Officer Sale of securities on an exchange or to another person at price $ 40.04 per share. 31 Mar 2025 21,574 7,993,602 - 40.0 863,896 Ordinary Shares
Organon & Co.
Kevin Ali Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. 31 Mar 2025 21,553 239,134 - 14.5 312,734 Common Stock
Amylyx Pharmaceuticals Inc
Joshua Cohen Director, Co-Chief Executive Officer Sale of securities on an exchange or to another person at price $ 3.47 per share. 31 Mar 2025 21,490 3,355,280 - 3.5 74,482 Common Stock
Amylyx Pharmaceuticals Inc
Justin Klee Director, Co-Chief Executive Officer Sale of securities on an exchange or to another person at price $ 3.46 per share. 31 Mar 2025 21,490 3,355,276 - 3.5 74,454 Common Stock
Organon & Co.
Kevin Ali Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 21,472 0 - - Restricted Stock Units
Organon & Co.
Kevin Ali Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 21,472 260,606 - 0 Common Stock
Universal Technical Instit...
Adrienne DeTray SVP and CIO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 21,242 21,242 (0%) 0% 0 Common Stock, $0.0001 par value
Core & Main Inc - Ordinary...
Robyn Bradbury Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 21,192 21,192 - - Options (Rights to Buy)
TJX Companies, Inc.
Kenneth Canestrari SEVP - Group President Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.80 per share. 31 Mar 2025 21,156 119,056 (0%) 0% 121.8 2,576,801 Common Stock
Purple Innovation Inc - Or...
Eric S. Haynor Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 21,101 42,202 - - Restricted Stock Units
Purple Innovation Inc - Or...
Eric S. Haynor Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 21,101 213,034 (1%) 0% - Class A Common Stock
Aura Biosciences Inc
Teresa Marie Bitetti Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 21,000 21,000 - 0 Common Stock
Ardent Health Partners Inc
Ethan Chernin President of Health Services Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 20,914 35,988 - 0 Common Stock
PPL Corp
David J. Bonenberger EVP & COO-Utilities Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 20,770 20,770 - - Stock Unit (SIP)
Lulus Fashion Lounge Holdi...
Dara Bazzano Director, Board Chair Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 20,694 148,732 - 0 Common Stock
Lindblad Expeditions Holdi...
Frederick Goldberg Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 20,496 70,496 (0%) 0% 0 Common Stock
Stagwell Inc - Ordinary Sh...
Ryan Greene Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share. 31 Mar 2025 20,395 190,597 - 5.9 120,942 Class A Common Stock
Hillenbrand Inc
Robert M. VanHimbergen Sr. VP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 20,239 20,239 - - Restricted Stock Units (Matching RSU Framework 03/31/2025)
Organon & Co.
Daniel Karp Executive VP, Corp. Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 20,147 20,147 - - Restricted Stock Units
Abercrombie & Fitch Co. - ...
Samir Desai EVP;Chief Digital&Tech Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.37 per share. 31 Mar 2025 20,001 54,804 (0%) 0% 76.4 1,527,476 Class A Common Stock
McCormick & Co., Inc. - Or...
Jeffery D. Schwartz Vice President, Gen Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.96 per share. 31 Mar 2025 20,000 89,958 (0%) 0% 50.0 999,200 Common Stock - Voting
McCormick & Co., Inc. - Or...
Jeffery D. Schwartz Vice President, Gen Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 20,000 20,000 - - Options - Right to Buy
Lesaka Technologies Inc
Ali Haeri Mazanderani Director, Executive Chairman Purchase of securities on an exchange or from another person at price $ 4.96 per share. 31 Mar 2025 20,000 525,115 (0%) 0% 5.0 99,200 Common Stock
Beam Therapeutics Inc
Christine Bellon Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 20,000 122,968 (0%) 0% 0 Common Stock
LifeMD Inc
Maria Stan Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 20,000 187,500 - 0 Common Stock
LifeMD Inc
Maria Stan Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 20,000 207,500 - 0 Common Stock
Angi Inc - Ordinary Shares...
Andrew Russakoff CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 20,000 20,000 - - Restricted Stock Units
Frontdoor Inc.
Kathryn M. Collins SVP & Chief Revenue Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 19,721 19,721 - - Restricted Stock Units
TJX Companies, Inc.
Carol Meyrowitz Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 19,705 228,315 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.